Sort   by:  
 Page size 
Epigenetic aberration is one of the major driving factors in human cancer, often leading to acquired resistance to chemotherapies. Various chemical epigenetic modulators have been reported. Nonetheless, outcomes from animal models and clinical trials have underscored the substantial setbacks attribu...
ORGANISM(S): Homo sapiens (Human) 
2025-05-06 | PXD048673 | Pride
Epigenome editing durability varies widely across cardiovascular disease target genes
Epigenome editing strategies for the functional annotation of topological insulators
Chem-CRISPR/dCas9FCPF - a platform for chemically induced epigenome editing
A modular dCas9-based recruitment platform for combinatorial epigenome editing
Sort   by:  
 Page size